Elicio Therapeutics, Inc.

ELTX

Elicio Therapeutics, Inc.

ELTX

Insider Sentiment (TTM):

Last Purchase:2023-12-22Last Sale:2021-12-20Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,618,498Shares Outstanding:18,211,745Institutional Ownership Pct.:14.38%

Earnings Market Reaction:

Filing Date:2026-08-13Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Related Party	-	-	-	-	-	-	-	20	-	-	-	-
Assets Current
Cash And Cash Equivalents At Carrying Value	23	15	19	21	22	18	18	26	3	12	13	15
Restricted Cash Current	-	-	0	0	0	1	1	1	0	1	1	2
Prepaid Expense And Other Assets Current	2	1	1	1	1	2	2	3	3	2	3	3
Assets Current	25	16	19	21	23	21	21	31	7	14	16	20
Property Plant And Equipment Net	0	0	0	0	0	0	0	1	1	1	1	1
Operating Lease Right Of Use Asset	4	5	5	5	5	5	6	6	6	6	7	7
Restricted Cash Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Prepaid Expense Other Noncurrent	1	1	1	1	1	1	1	1	2	3	3	3
Assets	31	23	26	28	30	28	28	38	16	24	27	31
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	1	0	1	0	4	4	1	2	1	1	4	4
Accrued Liabilities Current	7	6	6	5	5	6	8	5	5	3	4	4
Contract With Customer Liability Current	-	-	0	0	0	1	1	1	0	1	1	2
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Liabilities Current	9	7	8	7	10	11	12	9	8	6	10	11
Deferred Compensation Share Based Arrangements Lia…	-	-	-	-	-	-	0	0	0	0	0	0
Operating Lease Liability Noncurrent	4	4	4	4	5	5	5	5	6	6	6	6
Convertible Long Term Notes Payable	-	-	-	-	-	0	20	-	-	-	0	-
Long Term Debt Noncurrent	10	9	9	10	9	-	20	-	-	-	-	-
Liabilities	23	24	24	24	28	19	39	57	17	20	16	18
Deferred Compensation Sharebased Arrangements Liab…	-	-	-	-	-	-	-	-	-	-	0	0
Statement Of Stockholders…
Preferred Stock Value	-	-	0	-	-	-	0	0	0	0	0	-
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Temporary Equity
Treasury Stock Common Value	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Additional Paid In Capital	262	244	235	230	218	214	183	161	160	159	154	147
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	-	0	0
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-254	-245	-234	-226	-216	-205	-194	-180	-161	-154	-142	-133
Stockholders Equity	8	-1	2	4	2	9	-11	-19	-2	5	11	13
Liabilities And Stockholders Equity	31	23	26	28	30	28	28	38	16	24	27	31
Temporary Equity Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	0
Preferred Stock Par Or Stated Value Per Share	-	-	0.01	-	-	-	0.01	0.01	0.01	0.01	0.01	-
Preferred Stock Shares Authorized	-	-	10	-	-	-	10	10	10	10	10	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	0	0	0	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	0	0	0	0	-
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Series A Preferred Stock	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Shares Issued	22	19	18	17	16	16	11	11	10	10	10	8
Series B Preferred Stock	-	-	-	-	-	-	-	-	-	-	0	0
Shares Outstanding	22	19	18	17	16	16	11	11	10	10	10	8
Series C Preferred Stock	-	-	-	-	-	-	-	-	-	-	0	0
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	14.21%	-72.27%	-74.94%	-	-	-	-	-	-	-	-	-
2025	37.13%	38.53%	74.78%	16.10%	21.28%	6.95%	-12.18%	-11.64%	-16.58%	-2.29%	-1.38%	4.95%
2024	-24.71%	-64.71%	-51.35%	-6.62%	1.55%	1.32%	-6.92%	8.08%	79.04%	-16.72%	-8.12%	30.68%
2023	-	-	-	-13.80%	-25.00%	-34.90%	1.70%	20.54%	-25.30%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.77	2.24	2.38	3.29	2.28	1.83	1.80	3.40	0.88	2.37	1.68	1.74
Quick Ratio	2.55	2.07	2.29	3.16	2.23	1.67	1.63	3.03	0.50	2.10	1.40	1.44
Working Capital	16.28M	8.97M	11.20M	14.95M	12.68M	9.52M	9.17M	21.63M	-896.00K	8.18M	6.59M	8.45M
Leverage & Debt
Debt to Equity	2.95	-16.79	14.81	6.41	15.10	2.16	-3.49	-3.02	-10.53	4.03	1.39	1.33
Interest Coverage TTM	-24.00	-27.55	-33.29	-41.16	-60.34	-76.44	-98.87	-182.59	-469.64	-50.71	-33.75	-9.41
Debt Ratio	0.75	1.06	0.94	0.87	0.94	0.68	1.40	1.49	1.10	0.80	0.58	0.57
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.97	-2.21	-2.58	-2.75	-3.40	-3.96	-4.25	-3.45	-3.43	-3.80	-6.96	-3.07
Free Cash Flow Per Share TTM	-1.88	-2.11	-2.41	-1.73	-1.56	-2.71	-3.04	-2.82	-3.21	-3.57	-6.48	-3.61
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-	-	-	-	-100.00%	-100.00%	-100.00%
Net Income Growth (1Y)	-30.71%	-21.64%	-23.75%	-2.10%	41.25%	31.51%	47.46%	82.15%	73.71%	77.27%	24.77%	85.72%
EPS Growth (1Y)	-42.18%	-44.27%	-39.24%	-20.34%	-0.74%	4.33%	-38.90%	12.33%	-55.46%	-94.41%	-92.20%	-92.96%
Valuation Metrics
P/E TTM	-1.99	-4.84	-3.08	-3.98	-2.27	-1.56	-1.20	-1.46	-1.20	-2.00	-1.20	-2.75
P/B TTM	9.48	-135.48	74.50	47.86	67.60	8.96	-5.50	-3.60	-28.08	16.03	3.71	5.33
Market Cap	75.25M	194.68M	121.89M	182.62M	123.98M	79.78M	62.24M	68.32M	46.38M	78.08M	42.17M	70.78M
Enterprise Value	60.79M	188.50M	112.73M	171.02M	110.53M	60.04M	62.78M	40.29M	41.87M	64.88M	27.87M	53.59M
Calculated Values
Free Cash Flow TTM	-36.18M	-38.49M	-36.97M	-28.83M	-25.01M	-35.15M	-37.16M	-38.26M	-36.22M	-36.73M	-32.76M	-30.24M
Net Debt	-14.46M	-6.18M	-9.16M	-11.59M	-13.45M	-19.73M	542.00K	-28.03M	-4.51M	-13.21M	-14.30M	-17.20M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-12-22Purchase

Owner: Gkcc,, Llc, Chudnovsky Ye…

Title: -

Shares: 1,213,000

Price/Share: $5.81

Value: $7,047,530.00

Shares Owned: 1,915,639

Relationship: Director,TenPercentOwner

Ownership: Indirect

2022-05-25Purchase

Owner: Venkatesan, Jay

Title: See Remarks

Shares: 11,313

Price/Share: $1.25

Value: $14,141.25

Shares Owned: 1,891,947

Relationship: Director,Officer

Ownership: Direct

2022-05-24Purchase

Owner: Venkatesan, Jay

Title: See Remarks

Shares: 32,200

Price/Share: $1.24

Value: $39,928.00

Shares Owned: 1,721,457

Relationship: Director,Officer

Ownership: Direct

2022-05-20Purchase

Owner: Nissenson, Allen

Title: -

Shares: 2,037

Price/Share: $1.18

Value: $2,403.66

Shares Owned: 9,383

Relationship: Director

Ownership: Direct

2021-12-28Purchase

Owner: Venkatesan, Jay

Title: See Remarks

Shares: 210,337

Price/Share: $2.66

Value: $559,496.42

Shares Owned: 1,639,257

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-12-22	Gkcc,, Llc, Chudnovsky Ye…	Director,TenPercentOwner	-	Indirect	Purchase	1,213,000	5.81	$7,047,530.00	1,915,639	4
2022-05-25	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	11,313	1.25	$14,141.25	1,891,947	4
2022-05-24	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	32,200	1.24	$39,928.00	1,721,457	4
2022-05-20	Nissenson, Allen	Director	-	Direct	Purchase	2,037	1.18	$2,403.66	9,383	4
2021-12-28	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	210,337	2.66	$559,496.42	1,639,257	4
2021-12-20	Neylan, John F.	Officer	See Remarks	Direct	Sale	358	2.62	$937.96	35,136	4
2021-12-20	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	3,527	2.54	$8,958.58	1,362,013	4
2021-12-17	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	13,742	2.54	$34,904.68	1,358,486	4
2021-12-15	Curhan, Gregory S	Officer	See Remarks	Direct	Purchase	4,000	2.37	$9,480.00	4,000	4
2021-12-15	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Purchase	77,604	2.41	$187,025.64	1,316,861	4
2021-12-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	451	2.42	$1,091.42	30,399	4
2021-12-06	Goldberg, Itzhak	Director,Officer	See Remarks	Direct	Sale	32,118	3.35	$107,595.30	1,720,068	4
2021-12-03	Goldberg, Itzhak	Director,Officer	See Remarks	Direct	Sale	40,215	3.39	$136,328.85	1,752,186	4
2021-11-18	Neylan, John F.	Officer	See Remarks	Direct	Sale	374	4.13	$1,544.62	35,494	4
2021-11-16	Goldberg, Itzhak	Officer	See Remarks	Direct	Sale	38,495	4.26	$163,988.70	1,870,068	4
2021-11-15	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	433	4.40	$1,905.20	30,850	4
2021-10-18	Neylan, John F.	Officer	See Remarks	Direct	Sale	373	8.62	$3,215.26	35,868	4
2021-10-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	430	8.65	$3,719.50	31,283	4
2021-09-20	Neylan, John F.	Officer	See Remarks	Direct	Sale	376	10.07	$3,786.32	36,241	4
2021-09-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	430	10.64	$4,575.20	31,713	4
2021-08-18	Neylan, John F.	Officer	See Remarks	Direct	Sale	381	9.03	$3,440.43	36,617	4
2021-08-16	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	445	10.68	$4,752.60	32,143	4
2021-07-21	Neylan, John F.	Officer	See Remarks	Direct	Sale	365	10.98	$4,007.70	36,998	4
2021-07-21	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	432	10.94	$4,726.08	32,588	4
2021-07-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	431	11.01	$4,745.31	32,589	4
2021-06-18	Neylan, John F.	Officer	See Remarks	Direct	Sale	366	13.20	$4,831.20	37,363	4
2021-06-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	427	13.27	$5,666.29	33,020	4
2021-05-18	Neylan, John F.	Officer	See Remarks	Direct	Sale	363	13.91	$5,049.33	37,729	4
2021-05-14	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	440	13.92	$6,124.80	33,447	4
2021-04-19	Neylan, John F.	Officer	See Remarks	Direct	Sale	381	13.55	$5,162.55	38,092	4
2021-04-15	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	399	15.01	$5,988.99	33,887	4
2021-03-17	Neylan, John F.	Officer	See Remarks	Direct	Sale	442	19.13	$8,455.46	38,453	4
2021-03-13	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	499	20.45	$10,204.55	34,286	4
2021-02-13	Rhodes, Jennifer J	Officer	See Remarks	Direct	Sale	457	19.54	$8,929.78	34,785	4
2021-02-09	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Sale	159,177	16.00	$2,546,832.00	1,367,263	4/A
2021-02-09	Ganzi, Victor F	Director	-	Direct	Sale	246,720	16.00	$3,947,520.00	576,397	4
2021-02-09	Ganzi, Victor F	Director	-	Direct	Sale	246,720	16.00	$3,947,520.00	823,117	4/A
2021-02-09	Venkatesan, Jay	Director,Officer	See Remarks	Direct	Sale	159,177	16.00	$2,546,832.00	1,208,086	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

14.38%

Inst. Shares: 2,618,498

Shares Outstanding: 18,211,745

2025-12-31

13.58%

Inst. Shares: 2,079,772

Shares Outstanding: 15,312,751

2025-09-30

11.64%

Inst. Shares: 1,943,170

Shares Outstanding: 16,692,476

2025-06-30

9.03%

Inst. Shares: 1,450,816

Shares Outstanding: 16,059,423

2025-03-31

12.29%

Inst. Shares: 1,591,744

Shares Outstanding: 12,950,574

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,618,498	18,211,745	14.38%
2025-12-31	2,079,772	15,312,751	13.58%
2025-09-30	1,943,170	16,692,476	11.64%
2025-06-30	1,450,816	16,059,423	9.03%
2025-03-31	1,591,744	12,950,574	12.29%
2024-12-31	454,072	12,202,996	3.72%
2024-09-30	491,473	13,582,345	3.62%
2024-06-30	648,667	11,284,853	5.75%
2024-03-31	394,630	10,273,925	3.84%
2023-12-31	316,341	5,056,225	6.26%
2023-09-30	330,578	8,376,384	3.95%
2023-06-30	220,480	2,893,244	7.62%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Elicio Therapeutics, Inc. (ELTX) — SEC Financial Statements & Analysis

Elicio Therapeutics, Inc. (ELTX) is a pharmaceutical preparations company, incorporated in DE. Elicio Therapeutics, Inc. trades on Nasdaq as: ELTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Elicio Therapeutics, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 2.95x, a Price-to-Book (P/B) ratio of 9.48x (TTM), at a market cap of $75.25M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: 2.95x
P/B TTM: 9.48x
Market Cap: $75.25M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Elicio Therapeutics, Inc. in?

Elicio Therapeutics, Inc. (ELTX) operates in the Pharmaceutical Preparations industry.

What is ELTX's market cap?

Elicio Therapeutics, Inc. (ELTX) has a market capitalization of $75.25M as of 2026-06-30.

What exchange does ELTX trade on?

Elicio Therapeutics, Inc. (ELTX) trades on the Nasdaq.

Where is Elicio Therapeutics, Inc. incorporated?

Elicio Therapeutics, Inc. is incorporated in DE.